Table 1.

Baseline comparison of patients in the experimental group and the control group.

Characteristics	Experimental group (n = 18)	Control group (n = 16)	p value
Age (years)	56.88 ± 10.99	60.81 ± 9.61	0.337
Onset time (months)	2.50 ± 4.00	3.50 ± 3.00	0.208
Male/female	14/4	13/3	0.803
Injury site (left/right)	11/7	8/8	0.515
FMA-LE	20.69 ± 6.76	17.31 ± 6.64	0.114
FAC	3.00 ± 1.00	3.00 ± 0.00	0.087
MAS	1.00 ± 1.00	1.00 ± 1.00	0.453
Walking speed	0.26 ± 0.19	0.31 ± 0.19	0.704
Symmetry index	0.51 ± 0.19	0.60 ± 0.25	0.678
Affected stride length	0.43 ± 0.22	0.52 ± 0.18	0.523
Unaffected stride length	0.56 ± 0.20	0.47 ± 0.23	0.469
Affected hip ROM	20.17 ± 7.51	22.69 ± 10.41	0.933
Unaffected hip ROM	34.40 ± 8.15	33.50 ± 13.50	0.938
Affected knee flexion	31.95 ± 17.45	28.94 ± 14.17	0.208
Unaffected knee flexion	61.60 ± 15.25	56.90 ± 11.67	0.717
Affected ankle ROM	18.12 ± 6.13	18.84 ± 8.22	0.820
Unaffected ankle ROM	24.38 ± 8.24	23.67 ± 9.27	0.829
6MWT	91.80 ± 141.00	117.70 ± 71.41	0.523

Values denote means ± SD unless specified otherwise. The skewed distributed variables (onset time, MAS, walking speed of the experimental group, symmetry index of the experimental group, affected stride length of the experimental group, unaffected stride length of the control group, unaffected hip ROM of the experimental group, unaffected knee flexion of the experimental group, and 6MWT of the experimental group) were presented as median ± interquartile range (IQR).